Effect of antipsychotic drugs on the firing of dorsal raphe cells. I. Role of adrenergic system

https://doi.org/10.1016/0014-2999(76)90144-8Get rights and content

Abstract

The activity of serotonergic (5HT) neurons in the dorsal raphe nucleus was inhibited by the i.v. administration of certain antipsychotic drugs (methiothepin, clozapine and thioridazine). However, other antipsychotic agents (chlorpromazine, haloperidol and pimozide) did not inhibit raphe cell firing. The inhibitory potency of these drugs on raphe activity correlates with reported central noradrenergic blocking efficacy. An α-adrenergic blocking agent, piperoxane, but not the α-blocking agents, propranolol and MJ 1999, inhibited raphe activity when administered systemically. All of these drugs appear to act indirectly since they (and NE) have relatively weak or variable effects when applied microiontophoretically to raphe neurons.

The depressant effects of certain antipsychotic drugs and piperoxane on 5HT neurons appears to be mediated by a central adrenergic system since (1) the depression could be reversed by the catecholamine releasing agents 1- and d-amphetamine; (2) the depression could be abolished by destruction of adrenergic pathways in the CNS by chemical, mechanical, or electrothermic lesions. While a precise localization has not yet been obtained, the data suggest that these drug effects may be mediated by an adrenergic pathway ascending from the lower brainstem.

References (78)

  • D. Gallager et al.

    Inhibition of firing of raphe neurons by tryptophan and 5-hydroxytryptopham: Blockade by inhibiting serotonin synthesis with R04-4602

    Neuropharmacol.

    (1976)
  • H. Haigler et al.

    Mescaline and LSD: direct and indirect effects on serotonin-containing neurons in brain

    European J. Pharmacol.

    (1973)
  • J. Harris et al.

    Uptake of (3H)-catecholamines by homogenates of rat corpus striatum and cerebral cortex effects of amphetamine analogues

    Neuropharmacol.

    (1973)
  • B. Hoffer et al.

    Studies on norepinephrine-containing afferents to Purkinje cells of rat cerebellum. II. Sensitivity of Purkinje cells to norepinephrine and related substances administered by microiontophoresis

    Brain Res.

    (1971)
  • T. Hökfelt et al.

    Immunohistochemical evidence for the existence of adrenaline neurons in the rat brain

    Brain Res.

    (1974)
  • H. Keller et al.

    Increase of 3-methoxy-4-hydroxyphenylethylene glycol in rat brain by neuroleptic drugs

    European J. Pharmacol.

    (1973)
  • W. Kostowski et al.

    Biochemical aspects of the interaction between midbrain raphe and locus coeruleus in the rat

    Brain Res.

    (1974)
  • L. Loizou

    Projections of the nucleus locus coeruleus in the albino rat

    Brain Res.

    (1969)
  • H. Nybäck et al.

    Further studies on the accumulation and disappearance of catecholamines formed from tyrosine-C14in mouse brain. Effect of some phenothiazine analogues

    European J. Pharmacol.

    (1970)
  • M. Roizen et al.

    Studies on the origin of innervation of the noradrenergic area bordering on the nucleus raphe dorsalis

    Brain Res.

    (1976)
  • M. Scheibel et al.

    Do raphe nuclei of the reticular formation have a neurosecretory or vascular sensor function?

    Exptl. Neurol.

    (1975)
  • A. Sclafani et al.

    Hyperphagia produced by knife cuts between the medial and lateral hypothalamus in the rat

    Physiol. Behav.

    (1969)
  • D. Stein et al.

    Effects of α-methyl-p-tyrosine upon cerebral amine metabolism and sleep states in the cat

    Brain Res.

    (1974)
  • T. Svensson et al.

    Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine

    Brain Res.

    (1975)
  • K. Tasaki et al.

    A simple direct and rapid method for filling microelectrodes

    Physiol. Behav.

    (1968)
  • G. Aghajanian et al.

    Action of psychotogenic drugs on single midbrain raphe neurons

    J. Pharmacol. Exptl. Therap.

    (1970)
  • G. Aghajanian et al.

    Serotonin-containing neurons in brain: depression of firing by monoamine oxidase inhibitors

    Science

    (1970)
  • N.-E. Andén et al.

    Adrenergic receptor blocking agents: effects on central noradrenaline and dopamine receptors and on motor activity

    Psychopharmacologia

    (1974)
  • J. Angst et al.

    Das Klinische wirkungsbild von Clozapine

    Pharmakopsychiat. Neuropsychopharmakol.

    (1971)
  • G. Bartholini et al.

    Effects of clozapine on central catecholaminergic neurone systems

    Brit. J. Pharmacol.

    (1972)
  • H. Berzewski et al.

    Das klinische wirkungspektrum eines neuen dibenzodiazepin derivates

    Arzneim. Forsch.

    (1969)
  • A. Björklund et al.

    5,7-Dihydroxytryptamine: improvement of its selectivity for serotonin neurons in the CNS by pretreatment with desipramine

    J. Neurochem.

    (1975)
  • J. Boisser et al.

    Effects centraux de quelques substances adréno-et/ou sympatholytiques. II. Action sur la motilité spontanée et potentialisation du pentobarbital

    Arch. Intern. Pharmacodyn.

    (1967)
  • G. Bramwell et al.

    Responses of midbrain neurons to iontophoretically applied 5-hydroxytryptamine

    Brit. J. Pharmacol.

    (1973)
  • B. Bunney et al.

    D & L amphetamine stereoisomers: comparative potencies in affecting the firing of central dopaminergic and noradrenergic neurons

    Psychopharmacol. Commun.

    (1975)
  • H. Bürki et al.

    Effects of clozapine, thioridazine, perlapine and haloperidol on the metabolism of the biogenic amines in the brain of the rat

    Psychopharmacologia

    (1975)
  • A. Carlsson et al.

    Accumulation of 5-hydroxytryptophan in mouse brain after decarboxylase inhibition

    J. Pharm. Pharmacol.

    (1970)
  • A. Dahlström et al.

    Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons

    Acta Physiol. Scand.

    (1964)
  • D. DeMaio

    Clozapine, a novel major tranquilizer

    Arzeim. Forsch.

    (1972)
  • Cited by (98)

    • Feeding behaviour after injection of α-adrenergic receptor agonists into the median raphe nucleus of food-deprived rats

      2012, Physiology and Behavior
      Citation Excerpt :

      The absence of feeding effects after treatment with PHE in the MnR of free-feeding rats could be due to elevated adrenergic inputs on serotonergic neurons [39,48]. It seems that the reduction of an adrenergic inhibitory influence in food-deprived rats allows for α1-adrenergic receptor activation by PHE, resulting in 5-HT release, since facilitatory control of 5-HT release is attributed to α1-adrenoceptors [21,30] situated on MnR serotonergic cell bodies [55]. In agreement with this suggestion, we have recently reported [47] that the blockade of α1-adrenergic receptors within the MnR of free-feeding rats resulted in hyperphagia accompanied by a reduction in the latency to start eating, an increase in feeding duration and an increase in feeding frequency.

    • Serotonin Interaction with Other Transmitter Systems

      2010, Handbook of Behavioral Neuroscience
      Citation Excerpt :

      It is well known that noradrenergic afferents from the LC innervate the DR (Baraban and Aghajanian, 1980; Peyron et al., 1996), which has been corroborated by the presence of noradrenaline and its uptake sites in the DR (Tejani-Butt, 1992; Ordway et al., 1997; Strazielle et al., 1999). Noradrenaline exert a tonic facilitation of serotonergic transmission through (1-adrenoceptors (Baraban and Aghajanian, 1980; Marwaha and Aghajanian, 1982; Vandermaelen and Aghajanian, 1983; Pan et al., 1994; Adell and Artigas, 1999; Bortolozzi and Artigas, 2003; Pudovkina et al., 2003) located in the DRN (Pieribone et al., 1994; Day et al., 1997), possibly in the cell bodies' of serotonergic neurons (Gallager and Aghajanian, 1976a). Consistent with their action on the firing rate of serotonergic neurons, (α1-adrenoceptor antagonists decrease the release of 5-HT in projection areas (Rouquier et al., 1994; Hjorth et al., 1995; de Boer et al., 1996; Pudovkina et al., 2003).

    • Investigation of the SSRI augmentation properties of 5-HT<inf>2</inf> receptor antagonists using in vivo microdialysis

      2006, Neuropharmacology
      Citation Excerpt :

      It is of note that, in addition to blocking 5-HT2 receptors, ketanserin has alpha1-adrenoreceptor antagonist properties. Previous data show that alpha1-adrenoreceptor antagonists inhibit 5-HT cell firing and release (Gallager and Aghajanian, 1976; Hjorth et al., 1995). However, it is unlikely that an action of ketanserin at alpha1-adrenoreceptors was significant in the present study as ketanserin alone had no effect on hippocampal 5-HT levels at the dose used.

    View all citing articles on Scopus
    View full text